Performance guarantees for individualized treatment rules

Abstract

Because many illnesses show heterogeneous response to treatment, there is increasing interest in individualizing treatment to patients [Arch. Gen. Psychiatry 66 (2009) 128--133]. An individualized treatment rule is a decision rule that recommends treatment according to patient characteristics. We consider the use of clinical trial data in the construction of an individualized treatment rule leading to highest mean response. This is a difficult computational problem because the objective function is the expectation of a weighted indicator function that is nonconcave in the parameters. Furthermore, there are frequently many pretreatment variables that may or may not be useful in constructing an optimal individualized treatment rule, yet cost and interpretability considerations imply that only a few variables should be used by the individualized treatment rule. To address these challenges, we consider estimation based on $l_1$-penalized least squares. This approach is justified via a finite sample upper bound on the difference between the mean response due to the estimated individualized treatment rule and the mean response due to the optimal individualized treatment rule.

Published in at http://dx.doi.org/10.1214/10-AOS864 the Annals of Statistics (http://www.imstat.org/aos/) by the Institute of Mathematical Statistics (http://www.imstat.org)

References in corpus (5)

• Simultaneous analysis of Lasso and Dantzig selector
• The sparsity and bias of the Lasso selection in high-dimensional linear regression
• Performance guarantees for individualized treatment rules
• High-dimensional generalized linear models and the lasso
• Sparsity oracle inequalities for the Lasso

Cited by in corpus (24)

• Estimating treatment effect heterogeneity in randomized program evaluation
• Performance guarantees for individualized treatment rules
• Statistical inference for the mean outcome under a possibly non-unique optimal treatment strategy
• Machine Learning Estimation of Heterogeneous Causal Effects: Empirical Monte Carlo Evidence
• Efficient augmentation and relaxation learning for individualized treatment rules using observational data
• Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data
• Experimental Evaluation of Individualized Treatment Rules
• Estimation of Optimal Individualized Treatment Rules Using a Covariate-Specific Treatment Effect Curve with High-dimensional Covariates
• Bridging the gap: Towards an Expanded Toolkit for AI-driven Decision-Making in the Public Sector
• Estimating Optimal Treatment Rules with an Instrumental Variable: A Partial Identification Learning Approach
• The use of covariates and random effects in evaluating predictive biomarkers under a potential outcome framework
• Evaluating the Effectiveness of Personalized Medicine with Software
• A Parsimonious Personalized Dose Finding Model via Dimension Reduction
• Selecting and ranking individualized treatment rules with unmeasured confounding
• Efficient adjustment sets in causal graphical models with hidden variables
• Robust Sample Weighting to Facilitate Individualized Treatment Rule Learning for a Target Population
• Learning Individualized Treatment Rules with Estimated Translated Inverse Propensity Score
• A reluctant additive model framework for interpretable nonlinear individualized treatment rules
• Applications of 0-1 Neural Networks in Prescription and Prediction
• Efficient Learning of Optimal Individualized Treatment Rules for Heteroscedastic or Misspecified Treatment-Free Effect Models
• Enhanced inference for distributions and quantiles of individual treatment effects in various experiments
• A Statistical Test for the Benefits of Personalizing Interventions
• Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments
• Estimating Potential Outcome Distributions with Collaborating Causal Networks